HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gold nanoparticle based dot-blot immunoassay for sensitively detecting Alzheimer's disease related β-amyloid peptide.

Abstract
A simple, sensitive gold nanoparticle (GNP)-based dot-blot immunoassay has been developed for detecting Alzheimer's disease related β-amyloid peptide 1-42 (Aβ(1-42)) down to a 50 pg mL(-1) level in aqueous solution. Practical samples (cerebrospinal fluid (CSF), cell culturing mediums and cell lysates) have been used to demonstrate the ability of the assay.
AuthorsChengke Wang, Dianjun Liu, Zhenxin Wang
JournalChemical communications (Cambridge, England) (Chem Commun (Camb)) Vol. 48 Issue 67 Pg. 8392-4 (Aug 28 2012) ISSN: 1364-548X [Electronic] England
PMID22796866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Gold
Topics
  • Alzheimer Disease (diagnosis)
  • Amyloid beta-Peptides (chemistry)
  • Cell Line
  • Gold (chemistry)
  • Humans
  • Immunoassay
  • Metal Nanoparticles (chemistry)
  • Models, Molecular
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: